These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34815421)

  • 41. Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.
    Davis AK; Agin-Liebes G; España M; Pilecki B; Luoma J
    J Psychoactive Drugs; 2022; 54(4):309-318. PubMed ID: 34468293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Psychedelic Experiences During the Early COVID-19 Pandemic: Findings From an International Online Survey.
    Evens R; Reiche S; Marek RM; Moon DU; Groß RE; Romanello A; Jalilzadeh Masah D; Scicchitano Böckheler M; Gutwinski S; Montag C; Mick I; Majić T
    Front Psychiatry; 2021; 12():732028. PubMed ID: 34803757
    [No Abstract]   [Full Text] [Related]  

  • 43. Philosophical strategies for nature of science based on worldviews: The quantum interference of single electron.
    Oh JY; Son YA; Han SK
    Heliyon; 2023 Sep; 9(9):e19331. PubMed ID: 37810080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Restructuring consciousness -the psychedelic state in light of integrated information theory.
    Gallimore AR
    Front Hum Neurosci; 2015; 9():346. PubMed ID: 26124719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice.
    Gorman I; Nielson EM; Molinar A; Cassidy K; Sabbagh J
    Front Psychol; 2021; 12():645246. PubMed ID: 33796055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychedelic unselfing: self-transcendence and change of values in psychedelic experiences.
    Kähönen J
    Front Psychol; 2023; 14():1104627. PubMed ID: 37388660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.
    Johnson MW; Garcia-Romeu A; Johnson PS; Griffiths RR
    J Psychopharmacol; 2017 Jul; 31(7):841-850. PubMed ID: 28095732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology.
    Winkelman MJ
    Front Pharmacol; 2021; 12():619890. PubMed ID: 33732156
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Psychedelic Personality: Personality Structure and Associations in a Sample of Psychedelics Users.
    Johnstad PG
    J Psychoactive Drugs; 2021; 53(2):97-103. PubMed ID: 33252034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increases in Psychological Flexibility Mediate Relationship Between Acute Psychedelic Effects and Decreases in Racial Trauma Symptoms Among People of Color.
    Davis AK; Xin Y; Sepeda ND; Garcia-Romeu A; Williams MT
    Chronic Stress (Thousand Oaks); 2021; 5():24705470211035607. PubMed ID: 34377878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey.
    Barnett BS; Beaussant Y; King F; Doblin R
    J Psychoactive Drugs; 2022; 54(3):269-277. PubMed ID: 34409921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers.
    Boehnke KF; Cox K; Weston C; Herberholz M; Glynos N; Kolbman N; Fields CW; Barron J; Kruger DJ
    Front Psychiatry; 2023; 14():1224551. PubMed ID: 37599880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.
    Barnett BS; Parker SE; Weleff J
    Int J Drug Policy; 2022 Jan; 99():103473. PubMed ID: 34624734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.
    Lea T; Amada N; Jungaberle H; Schecke H; Scherbaum N; Klein M
    Psychopharmacology (Berl); 2020 May; 237(5):1521-1532. PubMed ID: 32043165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
    Barnett BS; Greer GR
    J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychedelics and Psychotherapy.
    Nayak S; Johnson MW
    Pharmacopsychiatry; 2021 Jul; 54(4):167-175. PubMed ID: 33285578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.
    Barber GS; Dike CC
    Psychiatr Serv; 2023 Aug; 74(8):838-846. PubMed ID: 36987705
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.
    Lowe H; Toyang N; Steele B; Grant J; Ali A; Gordon L; Ngwa W
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.
    Révész D; Ona G; Rossi GN; Rocha JM; Dos Santos RG; Hallak JEC; Alcázar-Córcoles MÁ; Bouso JC
    Front Psychiatry; 2021; 12():687546. PubMed ID: 34220590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.